The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
- 
      
  
Diversity, Equity and Inclusivity in Parkinson's research, 2022Promoting Diversity, Equity and Inclusion in Parkinson’s Disease (PD) Research: Clinical Disease Course and Healthcare Access in Black People with PDStudy Rationale: Few studies have been conducted on the clinical disease course and healthcare access in Black people with Parkinson’s disease (PD) compared to their White counterparts, and the... 
- 
      
  
Diversity, Equity and Inclusivity in Parkinson's research, 2022Engaging the LGBTQIA+ Community, Caregivers and Care Providers in Research on Living with Parkinson’s DiseaseStudy Rationale: Four million LGBTQIA+ adults age 50 and above live in the United States. We know very little about the needs of those in the LGBTQIA+ community who are living with Parkinson’s disease... 
- 
      
  
Diversity, Equity and Inclusivity in Parkinson's research, 2022Assessing the Awareness, Perception, Diagnosis, and Treatment of Parkinson’s Disease in AfricaStudy Rationale: Parkinson’s disease (PD) is little known in most parts of Africa and its symptoms are often ascribed to normal aging or to an unknown disorder. Most health care facilities lack the... 
- 
      
  
Diversity, Equity and Inclusivity in Parkinson's research, 2022Risk Factors for Parkinson’s Disease Among Participants in the Black Women’s Health StudyStudy Rationale: Little is known about the incidence, clinical presentation and risk factors for Parkinson’s disease (PD) in Black women, yet the existing evidence suggest that they may have a worse... 
- 
      
  
, 2022The Heads-Up Trial: Exploring the Effects of Sleeping in a Head-up Tilt Position on Blood Pressure in Parkinson’s DiseaseStudy Rationale: Parkinson’s disease (PD) affects the function of the autonomic nervous system, which controls blood pressure (BP), often resulting in both a low BP upon rising (orthostatic... 
- 
      
  
Alpha-synuclein Seed Amplification Assay Program, 2022Quantifying Alpha-synuclein Aggregates Using Nanopore SensorStudy Rationale: Parkinson’s disease (PD) is associated with an accumulation of alpha-synuclein aggregates in the brain; however, the current methods used to identify these aggregates in biological... 
 
  Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.